Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112651) titled 'Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause' on Aug. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: Double (Participant, Investigator).
Primary Sponsor: ApexCPG LLC
Condition:
Vasomotor Symptoms
Intervention:
Dietary Supplement: CL25216
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 18, 2025
Target Sample Size: 80
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07112651
Published by HT Digital Content Services with perm...